We are live on ! Find out more
AUTL

Autolus Therapeutics
AUTL

63 hedge funds and large institutions have $129M invested in Autolus Therapeutics in 2021 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 20 increasing their positions, 10 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

267% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 6

100% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 10

31% more funds holding

Funds holding: 48 → 63 (+15)

15% more capital invested

Capital invested by funds: $113M → $129M (+$16.8M)

9.72% more ownership

Funds ownership: 24.11% → 33.82% (+9.7%)

Holders
63
Holders Change
+15
Holders Change %
+31.25%
% of All Funds
1.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
20
Reduced
10
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$15.9M
2
OM
Opaleye Management
Massachusetts
+$15.6M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$14.5M
4
IC
Ikarian Capital
Texas
+$9.3M
5
Capital International Investors
Capital International Investors
California
+$7.77M

Top Sellers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
-$5.1M
2
BBA
Baker Bros. Advisors
New York
-$2.37M
3
EP
Eversept Partners
New York
-$1.39M
4
GIM
Granahan Investment Management
Massachusetts
-$924K
5
Victory Capital Management
Victory Capital Management
Texas
-$541K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
26
Renaissance Technologies
New York
$467K +$4.68K +632 +0.8%
Two Sigma Investments
27
Two Sigma Investments
New York
$442K +$571K +77,140 New
Wells Fargo
28
Wells Fargo
California
$401K +$321K +43,361 +162%
RCM
29
Regency Capital Management
Hawaii
$350K +$452K +61,000 New
HJIM
30
Henry James International Management
New York
$310K +$400K +54,047 New
RE
31
RBC Europe
United Kingdom
$270K +$339K +45,750 +3,268%
Citadel Advisors
32
Citadel Advisors
Florida
$239K +$168K +22,661 +119%
California Public Employees Retirement System
33
California Public Employees Retirement System
California
$233K -$28.3K -3,817 -9%
New York State Common Retirement Fund
34
New York State Common Retirement Fund
New York
$197K – – –
Nomura Holdings
35
Nomura Holdings
Japan
$165K +$222K +30,000 New
Bank of America
36
Bank of America
North Carolina
$152K +$193K +26,033 +4,616%
CSS
37
Cubist Systematic Strategies
Connecticut
$149K +$192K +25,974 New
State Street
38
State Street
Massachusetts
$129K – – –
JF
39
Jump Financial
Illinois
$113K +$147K +19,795 New
UBS Group
40
UBS Group
Switzerland
$107K +$97.5K +13,170 +238%
Geode Capital Management
41
Geode Capital Management
Massachusetts
$90K – – –
WMSA
42
Weiss Multi-Strategy Advisers
New York
$80K -$34K -4,592 -25%
Two Sigma Advisers
43
Two Sigma Advisers
New York
$80K +$103K +13,900 New
N
44
Natixis
France
$72K +$93.3K +12,600 New
Goldman Sachs
45
Goldman Sachs
New York
$66K -$21.4K -2,891 -20%
Legal & General Group
46
Legal & General Group
United Kingdom
$63K – – –
HF
47
HRT Financial
New York
$62K +$80.6K +10,886 New
APA
48
American Portfolios Advisors
New York
$60.7K +$43.3K +5,850 +123%
Victory Capital Management
49
Victory Capital Management
Texas
$34K -$541K -73,106 -92%
Osaic Holdings
50
Osaic Holdings
Arizona
$34K +$5.55K +750 +15%
1
2
3

AUTL Hedge Fund Activity: Q1 2021 in Review

63 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Autolus Therapeutics (AUTL) for Q1 2021, worth a combined $129M — up 15% from $113M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new AUTL positions and 6 closed out — a net gain of 16 holders — while 20 added to existing stakes and 10 trimmed.

The largest buyer was Deerfield Management, opening a new position worth an estimated $15.9M. The largest seller was Franklin Resources, exiting entirely with an estimated $5.1M sold.

  • 63 institutional investors held Autolus Therapeutics (AUTL) as of Q1 2021, up from 48 in Q4 2020.
  • Funds reported $129M of Autolus Therapeutics stock for Q1 2021, up 15% quarter-over-quarter.
  • 22 funds opened new Autolus Therapeutics positions in Q1 2021 and 6 closed out, a net change of +16 holders.
  • The largest Autolus Therapeutics buyer in Q1 2021 was Deerfield Management, an estimated $15.9M added.
  • The largest Autolus Therapeutics seller in Q1 2021 was Franklin Resources, an estimated $5.1M sold.

Based on aggregated 13F filings for Q1 2021.